Hao Xinxin, Luo Wenting, Qiu Xueshan
Department of Pathology, The First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang 110001, China.
Department of Blood Transfusion, Shengjing Hospital of China Medical University, Shenyang 110004, China.
Open Life Sci. 2021 Jun 19;16(1):602-610. doi: 10.1515/biol-2021-0056. eCollection 2021.
The current study investigates the effect of transcription factor Prox1 on the proliferation, migration, and invasion ability of lung cancer.
Lung cancer cell lines (A549 and H446 cells) were transfected with Prox1NAD and siRNA, respectively. Thus, the A549 and H446 cells overexpressed Prox1 after transfection of Prox1NAD plasmids, and A549 and H446 cells have low expression of Prox1 after transfection with siRNA. Reverse transcriptase quantitative PCR and western blot analyses were used to detect Prox1 mRNA and protein expression in cells. Plate clone formation experiments and MTT experiments were used to detect cell proliferation. Western blot was used to detect the expression of Rho family-related proteins in cells.
Compared to untransfected wild-type A549 and H446 that served as blank controls, the expression level of Prox1mRNA and protein in A549 and H446 cells overexpressing Prox1 after plasmid transfection was high, while the expression level of Prox1mRNA and protein in A549 and H446 cells with low expression of Prox1 after siRNA transfection was low. With the increase of Prox1 expression, the expression of RhoA and RhoC increased, while the expression of RhoB decreased.
The finding of this study may provide a new approach for the treatment of lung cancer using targeted gene therapy.
本研究探讨转录因子Prox1对肺癌增殖、迁移和侵袭能力的影响。
分别用Prox1NAD和小干扰RNA(siRNA)转染肺癌细胞系(A549和H446细胞)。因此,转染Prox1NAD质粒后,A549和H446细胞过表达Prox1,而用siRNA转染后,A549和H446细胞中Prox1表达降低。采用逆转录定量聚合酶链反应(RT-qPCR)和蛋白质免疫印迹分析检测细胞中Prox1的信使核糖核酸(mRNA)和蛋白表达。平板克隆形成实验和MTT实验用于检测细胞增殖。蛋白质免疫印迹用于检测细胞中Rho家族相关蛋白的表达。
与作为空白对照的未转染野生型A549和H446相比,质粒转染后过表达Prox1的A549和H446细胞中Prox1 mRNA和蛋白的表达水平较高,而siRNA转染后Prox1表达降低的A549和H446细胞中Prox1 mRNA和蛋白的表达水平较低。随着Prox1表达的增加,RhoA和RhoC的表达增加,而RhoB的表达降低。
本研究结果可能为肺癌的靶向基因治疗提供一种新方法。